Global infection control market is projected to register a healthy CAGR of 14.0% in the forecast period of 2020 to 2027. The new market report contains data for the historic year 2018, the base year of calculation is 2019 and the forecast period is 2020 to 2027.

Market Segmentation:
Global Infection Control Market, By Product (Sterilization Products, Cleaning and Disinfection Products, Personal Protective Barriers, Endoscope Reprocessing Products, Antimicrobial Surfaces, Other Infection Control Products), Application (Surgical Instruments, Endoscopes, Ultrasound Probes, Others), Distribution Channel (Direct Tender, Retail Sales, Third Party Distributors), End User (Hospitals, Clinics, Medical Device Companies, Pharmaceutical and Biotechnology Companies, Laboratories, Others), Country (U.S., Canada, Mexico, Germany, France, U.K., Italy, Spain, Russia, Turkey, Belgium, Netherlands, Switzerland, and Rest of Europe, Japan, China, South Korea, India, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines, and Rest of Asia-Pacific, Brazil, Argentina, and Rest of South America, South Africa, Saudi Arabia, UAE, Israel, Egypt and Rest of Middle East and Africa) Industry Trends and Forecast to 2027

Some of the major factors contributing to the growth of the global infection control market are:

- Increase in geriatric population
- Increase in prevalence of hospital acquired infection

Market Players:

The key market players for global infection control market are listed below:

- 3M
- STERIS plc
- Getinge AB
- MMM Group
- Cantel Medical
- MATACHANA GROUP
- Ecolab
- BELIMED, INC.
- Cardinal Health
- Steelco S.p.A.
- Reckitt Benckiser Group plc
- Metrex Research, LLC.
- Stryker
- B. Braun Melsungen AG
- Covalon Technologies Ltd.
- SKYTRON, LLC
- Olympus Corporation of the Americas (A Subsidiary of Olympus Corporation)
- COLTENE Group
- Pal International
- MELAG Medizintechnik GmbH & Co. KG
- Cisa Production S.r.l. Unipersonale
- TERRAGENE SA
- The Clorox Company